Teva announced the launch of Acamprosate Calcium Delayed-Release Tablets, the generic version of Forest‘s Campral

Campral is a GABA/taurine analog indicated for the maintenance of abstinence from alcohol in alcohol-dependent patients who are abstinent at treatment initiation, in conjunction with psychosocial support. Its mechanism of action in maintenance of alcohol abstinence is not completely understood but data suggests it may interact with glutamate and GABA neurotransmitter systems centrally, and acamprosate restores this balance. 

Acamprosate Calcium is available in 333mg strength delayed-release tablets in 180-count bottles.  

For more information call (866) 832-8537 or visit